The global gastrointestinal stent market size was valued at USD 615.8 million in 2025 and is projected to grow from USD 647.8 million in 2026 to USD 980.6 million by 2034, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period.

The Gastrointestinal Stent Market is experiencing steady expansion driven by the increasing incidence of gastrointestinal disorders, cancers, and biliary diseases worldwide.

Market Overview

The gastrointestinal stent market plays an essential role in modern gastroenterology, offering minimally invasive solutions for managing strictures, blockages, and malignant obstructions in the digestive tract. These flexible tube-like devices—manufactured from metal, plastic, or biodegradable compounds—are placed via endoscopy to maintain luminal patency, alleviate symptoms, and significantly improve the overall quality of life for patients suffering from complex gastrointestinal conditions.

Market Insights

Market insights reveal that North America holds a dominant share of the global landscape, accounting for 41.88% in 2025 with a valuation of USD 257.9 million. Meanwhile, Europe and Asia Pacific are registering substantial growth rates due to rising healthcare expenditure, technological upgrades in ambulatory surgical centers, and broader adoption of advanced endoscopic procedures like ERCP.

Market Trends

• Growing adoption of metal stents featuring larger diameters for longer stent patency and reduced risk of occlusion in malignant cases.
• Increasing clinical guideline endorsements supporting specific stenting protocols, such as colonic stenting and esophageal stenting for malignant strictures.
• Rise in the migration of therapeutic endoscopies and advanced gastrointestinal stenting procedures into specialized ambulatory surgery centers (ASCs).

For detailed market insights, visit the Gastrointestinal Stent Market reports: https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932

Market Growth Factors

• Surging global prevalence of gastrointestinal conditions, including biliary diseases, esophageal cancer, and colorectal cancer.
• Technological advancements in stent materials and designs, alongside a high volume of annual endoscopic retrograde cholangiopancreatography (ERCP) procedures.
• Increasing patient and physician preference for minimally invasive therapeutic interventions over traditional, highly invasive open surgeries.

For request sample reports: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gastrointestinal-stent-market-114932

Competitor Analysis

The global competitive environment is characterized by the presence of prominent medical device leaders, including Boston Scientific Corporation and Olympus Corporation, alongside other emerging regional participants. Major industry players heavily focus on maintaining diverse product portfolios encompassing various diameters and materials, strategic geographic expansions, and targeted distribution arrangements to optimize their competitive market positioning.

Segmentation Analysis

The market is broadly segmented by product type into biliary stents, duodenal stents, colonic stents, esophageal stents, and others, with biliary stents generating the highest revenue share. Additional categorizations include material (metal, plastic, and others), application (biliary disease, colorectal cancer, inflammatory bowel disease, esophageal cancer, and gastric/duodenal cancer), and end-user (hospitals & ASCs, clinics, and others).